Lumos Diagnostics Holdings Share Price and Company Fundamentals
Last traded: Today at 5:11 AM
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Key Metrics
PE ratio
-
PB ratio
23.47
Dividend yield
-
Beta
0.54
Market cap
$213.96M
Enterprise value
$207.13M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://lumosdiagnostics.com |
| Mailing address | 2724 Loker Ave West Carlsbad CA 92010 United States |
| Phone / Fax | 855 586 6739 / |
Dividends
More: Lumos Diagnostics Holdings Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Lumos Diagnostics Holdings paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.LDX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Lumos Diagnostics Holdings.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Douglas Ward | CEO, MD & Director | ||
| Mr. Barrie Lambert | Chief Financial Officer | ||
| Mr. Anthony Favaloro | VP of Operations | ||
| Dr. Sacha Dopheide Ph.D. | Chief Technology Officer | ||
| Ms. Sarah Glubka | Vice President of Human Resources | ||
| Mr. Paul Kase | Senior Vice President of Commercial Operations | ||
| Ms. Tracy Weimar BA, MBA | Company Secretary | ||
| Ms. Annie Bell | Vice President of Medical Affairs | ||
| Amelia Stephens | Global Marketing and Awareness Consultant |
Profitability and management effectiveness
Profit margin
-57.93%
Operating margin
-75.50%
Return on assets
-21.17%
Return on equity
-108.29%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Lumos Diagnostics Holdings is 213.96M and its enterprise value is 207.13M. The enterprise value to revenue ratio of LDX is 16.70. The enterprise value to EBITDA ratio of LDX is -27.75.
The LDX's stocks Beta value is 0.54 making it 46% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Lumos Diagnostics Holdings (LDX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Lumos Diagnostics Holdings (ASX:LDX) Frequently Asked Questions
1. What is Lumos Diagnostics Holdings's Stock Symbol?
Lumos Diagnostics Holdings trades on ASX under the ticker symbol "LDX".
2. What is Lumos Diagnostics Holdings's stock price today?
One share of LDX stock can currently be purchased for approximately $0.27.
3. How can I contact Lumos Diagnostics Holdings?
Lumos Diagnostics Holdings's mailing address is 2724 Loker Ave West Carlsbad CA 92010 United States. The company can be reached via phone at 855 586 6739.
4. What is Lumos Diagnostics Holdings's official website?
The official website of Lumos Diagnostics Holdings is https://lumosdiagnostics.com.